Product information
| Brand | |
|---|---|
| Manufacturer | Takeda |
| Active substance | Vedolizumab |
| Strength | 300mg |
| Pack size | 1-300 mg vial |
Entyvio 300mg infusion 1 vial
$3,999.00
| Quantity | Price |
|---|---|
| 1 - 5 | $3,999.00 |
| 6 - 10 | $3,989.00 |
| 11 - 20 | $3,984.00 |
| 21+ | $3,979.00 |
Description
To treat adult patients with ulcerative colitis and Crohn’s disease utilize Entyvio. It is an integrin receptor antagonist. This product is manufactured by Takeda Pharmaceuticals, a Japanese pharmaceutical company. Entyvio is used for injection and supplied in a single-dose vial for injection.
